Streetbeat News

Stock Prices

NRSN

NeuroSense Therapeutics (NASDAQ:NRSN) reported a Q1 EPS of $(0.35), missing the analyst estimate of $(0.20) by 75%. This represents a 6.06% increase in losses compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 1:02 pm

VRA

Vera Bradley (NASDAQ:VRA) has been analyzed by 6 analysts, all of whom maintain a bullish stance. The average 12-month price target remains at $10.00. Despite revenue and profitability challenges, analysts continue to see potential in the stock.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 1:01 pm

MU

Micron shares are trading higher after Baird raised its price target from $150 to $172.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 1:00 pm

PG

Over the past three months, 7 analysts have evaluated Procter & Gamble (NYSE:PG), with a mix of bullish and somewhat bullish ratings. The average 12-month price target has increased to $176.43. Analysts have adjusted their ratings and price targets, reflecting their response to recent developments. Procter & Gamble has shown positive revenue growth and strong financial health, though its ROE is below industry benchmarks.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 1:00 pm

AKBA

Akebia Therapeutics has announced the appointment of Erik Ostrowski as Senior Vice President, Chief Financial Officer, and Chief Business Officer.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 1:00 pm

CL

Analysts have provided a range of ratings for Colgate-Palmolive (NYSE:CL) over the past three months, with a mix of bullish, somewhat bullish, and indifferent sentiments. The average 12-month price target has increased to $96.67, up 6.34% from the previous average. Recent analyst actions include several rating upgrades and increased price targets, reflecting positive sentiment towards the company's financial performance.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 1:00 pm

LDOS

LNG

ORCL

XLV

On CNBC's 'Halftime Report Final Trades,' analysts discussed their top stock picks. Oracle Corporation (NYSE:ORCL) plans to invest over $1 billion in AI and cloud computing in Spain but missed Q4 revenue and earnings estimates. The Health Care Select Sector SPDR Fund (NYSE:XLV) was recommended by Shannon Saccocia. Cheniere Energy, Inc. (NYSE:LNG) announced a $4 billion increase in its repurchase program and a 15% dividend hike. Leidos Holdings, Inc. (NYSE:LDOS) received a $738 million contract and reported strong Q1 results.

Portfolio Pulse from Avi Kapoor

June 24, 2024 | 12:59 pm

FXI

NVO

China's Medical Products Authority has approved Novo Nordisk's Type-2 diabetes treatment for entry into the Chinese market.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:57 pm

NVO

Correction issued for Novo Nordisk's ticker symbol, which is 'NVO'.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:56 pm

CG

SPY

David Rubenstein, Co-Founder of Carlyle Group, stated that the Federal Reserve is unlikely to cut interest rates before the upcoming elections. He also mentioned that the U.S. economy is performing well and is expected to grow by 2.5% this year.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:56 pm